X4 Pharmaceuticals, Inc (XFOR) insider trading.
In Q3 2026, insiders at X4 Pharmaceuticals, Inc reported 3 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 3 sales worth $356K.
- Transactions
- 3
- Purchases (P)
- 0
- Sales (S)
- 3
- Net shares, P minus S
- -80,555
- Insiders
- 3
- Last filed
- 2026-08-13
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Craig Adam R | Director, Officer · Executive Chairman | 1 | 0 | 1 |
| Volpone John | Officer · President | 1 | 0 | 1 |
| Kirske David | Officer · Chief Financial Officer | 1 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-12 | Craig Adam R | S (D) | 47,436 | $4.44 | 328,651 | Form 4 |
| 2026-08-12 | Volpone John | S (D) | 24,576 | $4.44 | 265,305 | Form 4 |
| 2026-06-30 | Kirske David | S (D) | 8,543 | $4.26 | 167,750 | Form 4 |
Transaction codes in this quarter
Get XFOR insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1501697&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · XFOR company page · X4 Pharmaceuticals, Inc on SEC.gov
Questions
Are insiders buying or selling X4 Pharmaceuticals, Inc (XFOR)?
In Q3 2026, insiders at X4 Pharmaceuticals, Inc reported 3 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 3 sales worth $356K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these X4 Pharmaceuticals, Inc insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/xfor.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.